Failed and Unadopted Treatments for Retinal Vein Occlusions
Author:
Browning David J.
Publisher
Springer New York
Reference67 articles.
1. Ameri H, Kim JG, Ratanapakorn T, Chader GJ, Humayun MS. Intravitreal and subretinal injection of tissue plasminogen activator (tPA) in the treatment of experimentally created retinal vein occlusion in rabbits. Retina. 2008;28:350–5.
2. Arciniegas A. Treatment of the occlusion of the central retinal vein by section of the posterior ring. Ann Ophthalmol. 1984;16:1081–6.
3. Bakri SJ, Beer PM. Choroidal neovascularization after radial optic neurotomy for central retinal vein occlusion. Retina. 2002;24:610–1.
4. Benner JD, Morse LS, Toth CA, Landers III MB, Hjelmeland LM. Evaluation of a commercial recombinant tissue-type plasminogen activator preparation in the subretinal space of the cat. Arch Ophthalmol. 1991;109:1731–6.
5. Binder S, Aggermann T, Brunner S. Long-term effects of radial optic neurotomy for central retinal vein occlusion consecutive interventional case series. Graefes Arch Clin Exp Ophthalmol. 2007;245:1447–52.